New drugs and new concerns: Gaining insight through Pharmacovigilance of direct acting Anti-Viral’s in chronic HCV patients

OBJECTIVE: The study aimed to assess the safety profile of Direct Acting Anti-Viral’s (DAAs) among patients with chronic Hepatitis C Virus (HCV). METHODS: This multicenter, analytical cross-sectional study was conducted in six gastroenterology and Hepatology centers including Liver Center Faisalabad...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashmi, Zahid Yasin, Zia, Muhammad Qasim, Bajwa, Akram, Ahmed, Maqsood, Anwer, Naveed, Raza, Mahwish, Baqar, Jaffer Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931287/
https://www.ncbi.nlm.nih.gov/pubmed/33679903
http://dx.doi.org/10.12669/pjms.37.2.3400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931287/
https://www.ncbi.nlm.nih.gov/pubmed/33679903
http://dx.doi.org/10.12669/pjms.37.2.3400

Ejemplares similares